EMBC vs OBIO: stock comparison and AI forecast
Embecta Corp. (EMBC) and Orchestra Biomed Holdings, Inc. (OBIO) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
EMBC Embecta Corp.
- Price
- $6.25 -31.7% · 6M
- Market Cap
- $354M
- P/E Ratio
- 5.2x
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
OBIO Orchestra Biomed Holdings, Inc.
- Price
- $5.69 +41.5% · 6M
- Market Cap
- $342M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- EMBC and OBIO have similar market capitalizations ($354M and $342M).
- Over the last six months OBIO returned +41.5% and EMBC -31.7%.
- EMBC turns 8.6% of its revenue into net income, against -184.6% for OBIO.
- EMBC yields 12.71% in dividends; OBIO pays none.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | EMBC | OBIO |
|---|---|---|
| Market Cap | $354M | $342M |
| P/E Ratio | 5.21x | – |
| P/B Ratio | – | 17.70x |
| Dividend Yield | 12.71% | – |
| EPS | $1.20 | $-0.99 |
| Book Value/Share | – | $0.32 |
| Revenue/Share | $17.98 | $0.53 |
| FCF/Share | $2.91 | $-0.98 |
Profitability & Margins
| Metric | EMBC | OBIO |
|---|---|---|
| ROE | – | -305.5% |
| ROA | 6.9% | -51.0% |
| ROIC | 26.4% | -56.7% |
| Gross Margin | 59.0% | 99.5% |
| Operating Margin | 21.9% | -181.4% |
| Net Margin | 8.6% | -184.6% |
| EBT Margin | 12.2% | -181.4% |
| Tax Rate | 30.2% | – |
Financial Health
| Metric | EMBC | OBIO |
|---|---|---|
| Current Ratio | 1.68x | 8.26x |
| Quick Ratio | 1.17x | 8.24x |
| D/E Ratio | – | 4.47x |
| Financial Leverage | – | 5.99x |
| Interest Coverage | 4.0x | -56.1x |
| Working Capital | $285M | $98M |
Cash Flow
| Metric | EMBC | OBIO |
|---|---|---|
| Operating Cash Flow | $174M | -$58M |
| Free Cash Flow | $165M | -$59M |
| Capital Spending | -$10M | -$780K |
| OCF Growth YoY | 29.6% | – |
| FCF Growth YoY | 24.4% | – |
| FCF/Sales | 16.2% | -184.8% |
| CapEx/Sales | 0.9% | 2.4% |
Operational Efficiency
| Metric | EMBC | OBIO |
|---|---|---|
| Asset Turnover | 0.81x | 0.28x |
| Receivables Turnover | 5.6x | 627.0x |
| Inventory Turnover | 1.9x | 0.6x |
| Fixed Assets Turnover | 3.5x | 15.6x |
| Days Sales Outstanding | 65 days | 1 days |
| Days Inventory | 187 days | 581 days |
| Payables Period | – | 14256 days |
| Cash Conversion Cycle | – | -13674 days |
Income Statement
| Metric | EMBC | OBIO |
|---|---|---|
| Total Revenue | $1.02B | $32M |
| Operating Income | $224M | -$58M |
| Net Income | $88M | -$59M |
| R&D Expense | $20M | $63M |
| SG&A Expense | $319M | $27M |
| Cost of Goods Sold | $417M | $160K |
Dividend & Shareholder Information
| Metric | EMBC | OBIO |
|---|---|---|
| Dividends Per Share | $0.79 | – |
| Payout Ratio | 65.8% | – |
| Shares Outstanding | 57M | 60M |
| Net Income Growth | 4.7% | – |
| EPS Growth | -35.8% | – |
EMBC vs OBIO: stock comparison and AI forecast
Which is bigger, EMBC or OBIO?
EMBC and OBIO have similar market capitalizations ($354M and $342M).
Which stock performed better over the last six months, EMBC or OBIO?
Over the last six months OBIO returned +41.5% and EMBC -31.7%.
Which one does Intratio's AI model rank higher, EMBC or OBIO?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.